Health & Science

Medical Malpractice

We’ve all heard alarming stories about the extent to which pharmaceutical companies have their hands in what appear to be objective studies on their products. So it comes as a great relief to many patients and physicians alike that there are medical journals to sniff out the real breakthroughs from the steaming piles of marketing hype. But can the peer-reviewed paragons of probity really escape the conflicts of interest that plague medical research in general? Bob takes a look at the story that’s not so evident in the pages of medical journals.


An Element of Confusion

The hydrogen economy that President Bush has embraced is getting mixed reviews from both industry groups and environmentalists, making it very difficult for energy consumers to get the straight story. But it may be discrepancies between the science and the policy that are polluting the reporting. Brooke speaks to Dr. Daniel Kamman about energizing the coverage of the hydrogen debate.


Supported in part by: